BIOMAT Database Logo BIOMAT Database Logo

Identification of heparin-binding sites in proteins by selective labeling. 2009

Alessandro Ori, and Paul Free, and José Courty, and Mark C Wilkinson, and David G Fernig
School of Biological Sciences and Centre for Glycobiology, University of Liverpool, Liverpool, United Kingdom.

Heparan sulfate proteoglycans are key regulators of complex molecular networks due to the interaction of their sugar chains with a large number of partner proteins, which in humans number more than 200 (Ori, A., Wilkinson, M. C., and Fernig, D. G. (2008) The heparanome and regulation of cell function: structures, functions and challenges. Front. Biosci. 13, 4309-4338). We developed a method to selectively label residues involved in heparin binding that matches the requirements for medium/high throughput applications called the "Protect and Label" strategy. This is based on the protection against chemical modification given by heparin/heparan sulfate to the residues located in the heparin-binding site. Thus, analysis of fibroblast growth factor-2 bound to heparin and incubated with N-hydroxysuccinimide acetate showed that lysines involved in the sugar binding are protected against chemical modification. Moreover following release from heparin, the protected lysine side chains may be specifically labeled with N-hydroxysuccinimide biotin. After protein digestion, the biotinylated peptides were readily isolated and identified by MALDI-Q-TOF mass spectrometry. The analysis of labeled peptides obtained from three well characterized heparin-binding proteins with very different heparin-binding sites, fibroblast growth factor-2, platelet factor-4, and pleiotrophin demonstrates the success of this new approach, which thus provides a rapid and reliable procedure to identify heparin-binding sites.

UI MeSH Term Description Entries
D008239 Lysine An essential amino acid. It is often added to animal feed. Enisyl,L-Lysine,Lysine Acetate,Lysine Hydrochloride,Acetate, Lysine,L Lysine
D008958 Models, Molecular Models used experimentally or theoretically to study molecular shape, electronic properties, or interactions; includes analogous molecules, computer-generated graphics, and mechanical structures. Molecular Models,Model, Molecular,Molecular Model
D008969 Molecular Sequence Data Descriptions of specific amino acid, carbohydrate, or nucleotide sequences which have appeared in the published literature and/or are deposited in and maintained by databanks such as GENBANK, European Molecular Biology Laboratory (EMBL), National Biomedical Research Foundation (NBRF), or other sequence repositories. Sequence Data, Molecular,Molecular Sequencing Data,Data, Molecular Sequence,Data, Molecular Sequencing,Sequencing Data, Molecular
D010455 Peptides Members of the class of compounds composed of AMINO ACIDS joined together by peptide bonds between adjacent amino acids into linear, branched or cyclical structures. OLIGOPEPTIDES are composed of approximately 2-12 amino acids. Polypeptides are composed of approximately 13 or more amino acids. PROTEINS are considered to be larger versions of peptides that can form into complex structures such as ENZYMES and RECEPTORS. Peptide,Polypeptide,Polypeptides
D011485 Protein Binding The process in which substances, either endogenous or exogenous, bind to proteins, peptides, enzymes, protein precursors, or allied compounds. Specific protein-binding measures are often used as assays in diagnostic assessments. Plasma Protein Binding Capacity,Binding, Protein
D011506 Proteins Linear POLYPEPTIDES that are synthesized on RIBOSOMES and may be further modified, crosslinked, cleaved, or assembled into complex proteins with several subunits. The specific sequence of AMINO ACIDS determines the shape the polypeptide will take, during PROTEIN FOLDING, and the function of the protein. Gene Products, Protein,Gene Proteins,Protein,Protein Gene Products,Proteins, Gene
D006493 Heparin A highly acidic mucopolysaccharide formed of equal parts of sulfated D-glucosamine and D-glucuronic acid with sulfaminic bridges. The molecular weight ranges from six to twenty thousand. Heparin occurs in and is obtained from liver, lung, mast cells, etc., of vertebrates. Its function is unknown, but it is used to prevent blood clotting in vivo and vitro, in the form of many different salts. Heparinic Acid,alpha-Heparin,Heparin Sodium,Liquaemin,Sodium Heparin,Unfractionated Heparin,Heparin, Sodium,Heparin, Unfractionated,alpha Heparin
D000085 Acetates Derivatives of ACETIC ACID. Included under this heading are a broad variety of acid forms, salts, esters, and amides that contain the carboxymethane structure. Acetate,Acetic Acid Esters,Acetic Acids,Acids, Acetic,Esters, Acetic Acid
D000595 Amino Acid Sequence The order of amino acids as they occur in a polypeptide chain. This is referred to as the primary structure of proteins. It is of fundamental importance in determining PROTEIN CONFORMATION. Protein Structure, Primary,Amino Acid Sequences,Sequence, Amino Acid,Sequences, Amino Acid,Primary Protein Structure,Primary Protein Structures,Protein Structures, Primary,Structure, Primary Protein,Structures, Primary Protein
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia

Related Publications

Alessandro Ori, and Paul Free, and José Courty, and Mark C Wilkinson, and David G Fernig
Docking server for the identification of heparin binding sites on proteins.
July 2014, Journal of chemical information and modeling,
Alessandro Ori, and Paul Free, and José Courty, and Mark C Wilkinson, and David G Fernig
Affinity labeling of binding sites in proteins by sensitized photooxidation.
January 1977, Methods in enzymology,
Alessandro Ori, and Paul Free, and José Courty, and Mark C Wilkinson, and David G Fernig
Differentiation of substrate-binding sites in pyruvate kinase by selective photoaffinity labeling.
October 1997, Biochemistry and molecular biology international,
Alessandro Ori, and Paul Free, and José Courty, and Mark C Wilkinson, and David G Fernig
Identification of L-glutamate binding sites in chick brain by photoaffinity labeling.
March 1989, European journal of pharmacology,
Alessandro Ori, and Paul Free, and José Courty, and Mark C Wilkinson, and David G Fernig
Identification of cyclic ADP-ribose-binding proteins by photoaffinity labeling.
December 1993, The Journal of biological chemistry,
Alessandro Ori, and Paul Free, and José Courty, and Mark C Wilkinson, and David G Fernig
Computational approaches to the identification of heparin-binding sites on the surfaces of proteins.
June 2006, Biochemical Society transactions,
Alessandro Ori, and Paul Free, and José Courty, and Mark C Wilkinson, and David G Fernig
Identification of calmodulin-binding proteins in pure mitochondria by photoaffinity labeling.
November 1986, Biochemistry international,
Alessandro Ori, and Paul Free, and José Courty, and Mark C Wilkinson, and David G Fernig
Identification of binding sites on the E. coli ribosome by affinity labeling.
January 1977, Advances in experimental medicine and biology,
Alessandro Ori, and Paul Free, and José Courty, and Mark C Wilkinson, and David G Fernig
Prediction of heparin binding sites in bone morphogenetic proteins (BMPs).
December 2012, Biochimica et biophysica acta,
Alessandro Ori, and Paul Free, and José Courty, and Mark C Wilkinson, and David G Fernig
Metal- and Affinity-Specific Dual Labeling of Cysteine-Rich Proteins for Identification of Metal-Binding Sites.
October 2020, Analytical chemistry,
Copied contents to your clipboard!